| Segment / region | Type | Fiscal year | Currency | Revenue (millions) | Share of revenue |
|---|---|---|---|---|---|
| Unitedhealthcare | Product | 2025 | USD | 332,390.0 | 94.4% |
| Optumhealth | Product | 2025 | USD | 19,839.0 | 5.6% |
| Unitedhealthcare | Product | 2024 | USD | 298,208.0 | 73.7% |
| Optumrx | Product | 2024 | USD | 133,231.0 | 32.9% |
| Optumhealth | Product | 2024 | USD | 105,358.0 | 26.0% |
| Optuminsight | Product | 2024 | USD | 18,757.0 | 4.6% |
| Intersegment Eliminations | Product | 2024 | USD | (150,887.0) | −37.3% |
| Unitedhealthcare | Product | 2022 | USD | 249,741.0 | 76.4% |
| Optumrx | Product | 2022 | USD | 99,773.0 | 30.5% |
| Optumhealth | Product | 2022 | USD | 71,174.0 | 21.8% |
| Optuminsight | Product | 2022 | USD | 14,581.0 | 4.5% |
| Intersegment Eliminations | Product | 2022 | USD | (108,347.0) | −33.1% |
| Unitedhealthcare | Product | 2021 | USD | 222,899.0 | 77.0% |
| Optumrx | Product | 2021 | USD | 91,314.0 | 31.5% |
| Optumhealth | Product | 2021 | USD | 54,065.0 | 18.7% |
| Optuminsight | Product | 2021 | USD | 12,199.0 | 4.2% |
| Intersegment Eliminations | Product | 2021 | USD | (90,867.0) | −31.4% |
| Unitedhealthcare | Product | 2020 | USD | 200,875.0 | 77.6% |
| Optumrx | Product | 2020 | USD | 87,498.0 | 33.8% |
| Optumhealth | Product | 2020 | USD | 39,808.0 | 15.4% |
| Optuminsight | Product | 2020 | USD | 10,802.0 | 4.2% |
| Intersegment Eliminations | Product | 2020 | USD | (80,042.0) | −30.9% |
| Unitedhealthcare | Product | 2019 | USD | 193,842.0 | 79.5% |
| Optumrx | Product | 2019 | USD | 74,288.0 | 30.5% |
| Optumhealth | Product | 2019 | USD | 30,317.0 | 12.4% |
| Optuminsight | Product | 2019 | USD | 10,006.0 | 4.1% |
| Intersegment Eliminations | Product | 2019 | USD | (64,637.0) | −26.5% |
Product and geographic breakdowns describe the same revenue from different perspectives and should not be added together.
